Skip to Main Content

Paper Details

ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.
bioRxiv
0
2023
AR, AR-dependent Cancers, Cancer, Cancer cells, TET2, Ten-Eleven Translocation 2, ZNF397, ZNF397 deficiency, ZNF397-deficient tumors, Zinc, Zinc Finger Protein 397, androgen, androgen receptor, cancer, cancer cell, cancer cells, luminal lineage, malignancies, prostate and breast cancers, prostate cancer, tumor

Datasets

Release 1.2